Meeder Asset Management’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.55K | Buy |
+170
| New | +$2.55K | ﹤0.01% | 799 |
|
|
2020
Q2 | – | Sell |
-9
| Closed | -$1K | – | 2451 |
|
|
2020
Q1 | $1K | Sell |
9
-39
| -81% | -$4.33K | ﹤0.01% | 2232 |
|
|
2019
Q4 | $10K | Buy |
48
+41
| +586% | +$8.54K | ﹤0.01% | 1568 |
|
|
2019
Q3 | $1K | Sell |
7
-6
| -46% | -$857 | ﹤0.01% | 2085 |
|
|
2019
Q2 | $2K | Sell |
13
-270
| -95% | -$41.5K | ﹤0.01% | 1880 |
|
|
2019
Q1 | $57K | Buy |
283
+78
| +38% | +$15.7K | ﹤0.01% | 843 |
|
|
2018
Q4 | $38K | Buy |
205
+64
| +45% | +$11.9K | ﹤0.01% | 888 |
|
|
2018
Q3 | $35K | Buy |
+141
| New | +$35K | ﹤0.01% | 886 |
|